Dramatic decline of serogroup C meningococcal disease in Catalonia (Spain) after a mass vaccination campaign with meningococcal C conjugated vaccine

By Salleras L.   Domnguez A.   Cardenosa N.  

Vaccine, Vol. 21, Iss. 7, 2003-01 ,pp. : 729-733

Elsevier

Access to resources Recommend Favorite

Impact of mass vaccination with polysaccharide conjugate vaccine against serogroup C meningococcal disease in Spain

By Salleras L.   Domnguez A.   Cardenosa N.  

Vaccine, Vol. 21, Iss. 7, 2003-01 ,pp. : 725-728

Elsevier

Access to resources Recommend Favorite

Comparison of antibody kinetics following meningococcal serogroup C conjugate vaccine between healthy adults previously vaccinated with meningococcal A/C polysaccharide vaccine and vaccine-nave controls

By Borrow R.   Southern J.   Andrews N.   Peake N.   Rahim R.   Acuna M.   Martin S.   Miller E.   Kaczmarski E.  

Vaccine, Vol. 19, Iss. 23, 2001-04 ,pp. : 3043-3050

Elsevier

Access to resources Recommend Favorite

Reduced antibody response to revaccination with meningococcal serogroup A polysaccharide vaccine in adults

By Borrow R.   Joseph H.   Andrews N.   Acuna M.   Longworth E.   Martin S.   Peake N.   Rahim R.   Richmond P.   Kaczmarski E.   Miller E.  

Vaccine, Vol. 19, Iss. 9, 2000-12 ,pp. : 1129-1132

Elsevier

Access to resources Recommend Favorite

An outbreak of serogroup C meningococcal disease in the province of Antwerp (Belgium) in 2001–2002

By de Schrijver K.   Maes I.  

European Journal of Epidemiology, Vol. 18, Iss. 11, 2003-11 ,pp. : 1073-1077

Springer Publishing Company

Access to resources Recommend Favorite